Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study (Q44990096)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study
scientific article

    Statements

    Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study (English)
    1 September 2004
    669-675

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit